Clinigen Group Plc, which services clinical trials and markets an antiviral drug to treat herbes viruses, will be listed on London’s Alternative Investment Market from 25 September - the first pharma IPO on the AIM market in five years. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
